Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vlatko Pejsa

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Radiology and Oncology|September 26, 2019
Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnairesSanja Ledinski Ficko, Vlatko Pejsa, Vesna Zadnik
Croatian Medical Journal|April 23, 2004
Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia AVlatko Pejsa, Ivica Grgurević, Rajko Kusec, et al.
Annals of Saudi Medicine|January 28, 2010
Reactive macrophage activation syndrome in a patient with parvovirus B19 infection, lymphocytic lichenoid vasculitis, urticaria and angioedemaDragica Soldo-Juresa, Maja Radman, Vlatko Pejsa, et al.
Annals of Hematology|November 14, 2018
Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemiaVlatko Pejsa, Marko Lucijanic, Zeljko Jonjic, et al.
Annals of Saudi Medicine|May 17, 2012
Diffuse skin hyperpigmentation in CD30+ lymphoproliferationZeljko Prka, Cedna Tomasovic-Loncaric, Vlatko Pejsa, et al.
Pharmacology|October 13, 2022
No Evident Prognostic Benefit of Statin Use in Diffuse Large B-Cell Lymphoma Patients with Unfavorable Disease Features Treated with R-DA-EPOCHAnica Sabljic, Martina Sedinic Lacko, Rajko Kusec, et al.
Therapeutics and Clinical Risk Management|October 1, 2021
More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable FeaturesMarko Lucijanic, Renata Huzjan Korunic, Martina Sedinic, et al.
Haematologica|December 23, 2003
Bone marrow and peripheral blood hematopoietic reserve in patients with B-cell chronic lymphocytic leukemiaVlatko Pejsa, Rajko Kusec, Mladen Petrovecki, et al.
American Journal of Hematology|April 26, 2005
Multicentric glial brain tumors of a varying degree of differentiation in patient with chronic lymphocytic leukemiaVlatko Pejsa, Ivica Grgurevic, Leo Pazanin, et al.
American Journal of Hematology|November 6, 2018
Bendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortalityMarko Lucijanic, Zeljko Prka, Ozren Jaksic, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Radiology and Oncology|September 26, 2019
Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnairesSanja Ledinski Ficko, Vlatko Pejsa, Vesna Zadnik
Croatian Medical Journal|April 23, 2004
Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia AVlatko Pejsa, Ivica Grgurević, Rajko Kusec, et al.
Annals of Saudi Medicine|January 28, 2010
Reactive macrophage activation syndrome in a patient with parvovirus B19 infection, lymphocytic lichenoid vasculitis, urticaria and angioedemaDragica Soldo-Juresa, Maja Radman, Vlatko Pejsa, et al.
Annals of Hematology|November 14, 2018
Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemiaVlatko Pejsa, Marko Lucijanic, Zeljko Jonjic, et al.
Annals of Saudi Medicine|May 17, 2012
Diffuse skin hyperpigmentation in CD30+ lymphoproliferationZeljko Prka, Cedna Tomasovic-Loncaric, Vlatko Pejsa, et al.
Pharmacology|October 13, 2022
No Evident Prognostic Benefit of Statin Use in Diffuse Large B-Cell Lymphoma Patients with Unfavorable Disease Features Treated with R-DA-EPOCHAnica Sabljic, Martina Sedinic Lacko, Rajko Kusec, et al.
Therapeutics and Clinical Risk Management|October 1, 2021
More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable FeaturesMarko Lucijanic, Renata Huzjan Korunic, Martina Sedinic, et al.
Haematologica|December 23, 2003
Bone marrow and peripheral blood hematopoietic reserve in patients with B-cell chronic lymphocytic leukemiaVlatko Pejsa, Rajko Kusec, Mladen Petrovecki, et al.
American Journal of Hematology|April 26, 2005
Multicentric glial brain tumors of a varying degree of differentiation in patient with chronic lymphocytic leukemiaVlatko Pejsa, Ivica Grgurevic, Leo Pazanin, et al.
American Journal of Hematology|November 6, 2018
Bendamustine-based conditioning prior to autologous stem cell transplantation is associated with high rate of febrile neutropenia and higher mortalityMarko Lucijanic, Zeljko Prka, Ozren Jaksic, et al.
Pageof 4